A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 9, 2001, Pages 495-502

  Akpek, Görgün ^a   Lee, Shing M ^a   Anders, Viki ^a   Vogelsang, Georgia B ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Chronic; Graft versus host disease; GVHD; Steroid treatment

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; ETRETINATE; FLUCONAZOLE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOSTATIN; PREDNISONE; PSORALEN; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY; VALACICLOVIR;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFECTION; JOINT MOBILITY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PROBABILITY; PUVA; SKIN; STATISTICAL ANALYSIS; SURVIVAL; TACHYCARDIA; TIME; TREATMENT FAILURE; VERTIGO;

EID: 0034781710     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2001.v7.pm11669216     Document Type: Article

References (22)

1. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: A comparison of complications in the first 2 years
2. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers
3. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle
4. A randomized trial of filgrastim (G-CSF) stimulated donor marrow (BM) versus peripheral blood (PBC) for allogeneic transplantation: Increased extensive chronic graft versus host disease following PBPC transplantation
5. Development of a prognostic model for grading chronic graft-versus-host disease
6. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease
7. Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
8. High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adults
9. High-dose methylprednisolone therapy for acute graft-versus-host disease associated with matched unrelated donor bone marrow transplantation
10. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: A multicenter randomized trial from the Italian Group for Bone Marrow Transplantation
11. Non parametric estimation from incomplete observations
12. The Statistical Analysis of Failure Time Data
13. Effect of glucocorticoid therapy on glucocorticoid receptors in children with autoimmune diseases
14. Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases
15. A new hypothesis of modular glucocorticoid actions: Steroid treatment of rheumatic disease revisited
16. The adenylate energy change in intact cells
17. Therapeutically targeting lymphocyte energy metabolism by high-dose glucocorticoids
18. Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy
19. Treatment of acute graft-versus-host disease with humanized anti- Tac: An antibody that binds to the interleukin-2 receptor
20. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
21. Treatment of GVHD-TNF antibodies and related antagonists
22. Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and IL-2 R antibody